Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9157655 | Atherosclerosis | 2005 | 13 Pages |
Abstract
These results indicate that a combined treatment with RAS-blockade and statins may have additive effects on systemic cardiovascular risk markers even in the absence of lipid-reduction, although additional effects on atherosclerotic plaque progression and stability were not observed in this model.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Christina Grothusen, Sylvia Bley, Tina Selle, Maren Luchtefeld, Karsten Grote, Uwe J.F. Tietge, Helmut Drexler, Bernhard Schieffer,